Macy's/$M
1D1W1MYTD1Y5YMAX
Capital at risk
About Macy's
Founded in 1858 and based in New York City, Macy's operates about 430 eponymous stores, 60 stores under the Bloomingdale's (full-price and outlet) and Bloomie's names, and 170 freestanding Bluemercury specialty beauty stores. Macy's also operates e-commerce sites and licenses Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances constituted 64% of 2025 net retail sales.
- Ticker
- $M
- Sector
- Consumer Essentials
- Primary listing
- NYSE
- Employees
- 90,134
- Headquarters
- New York, United States
- Website
- www.macysinc.com
Macy's Metrics
BasicAdvanced
$5.8B
8.10
$2.74
1.43
$0.75
3.44%
Price and volume
Market cap
$5.8B
Beta
1.43
52-week high
$26.59
52-week low
$16.41
Average daily volume
6.4M
Dividend rate
$0.75
Financial strength
Current ratio
1.59
Quick ratio
0.381
Long term debt to equity
1.033
Total debt to equity
1.033
Dividend payout ratio (TTM)
26.40%
Interest coverage (TTM)
9.34%
Profitability
EBITDA (TTM)
1,400
Gross margin (TTM)
40.28%
Net profit margin (TTM)
3.29%
Operating margin (TTM)
3.85%
Effective tax rate (TTM)
24.01%
Revenue per employee (TTM)
$250,000
Management effectiveness
Return on assets (TTM)
3.51%
Return on equity (TTM)
15.99%
Valuation
Price to earnings (TTM)
8.105
Price to revenue (TTM)
0.259
Price to book
1.18
Price to tangible book (TTM)
1.58
Price to free cash flow (TTM)
5.672
Free cash flow yield (TTM)
17.63%
Free cash flow per share (TTM)
3.921
Dividend yield (TTM)
3.36%
Forward dividend yield
3.44%
Growth
Revenue change (TTM)
0.35%
Earnings per share change (TTM)
55.46%
3-year revenue growth (CAGR)
-2.40%
10-year revenue growth (CAGR)
-1.46%
3-year earnings per share growth (CAGR)
0.50%
10-year earnings per share growth (CAGR)
0.96%
3-year dividend per share growth (CAGR)
5.03%
10-year dividend per share growth (CAGR)
-6.45%
What the Analysts think about Macy's
Analyst ratings (Buy, Hold, Sell) for Macy's stock.
Analyst projections of the future price of Macy's stock.
Bulls say / Bears say
Macy’s raised its fiscal 2026 sales outlook to $21.68–$21.83 billion and adjusted EPS outlook to $2.15–$2.35, following a quarterly sales and earnings beat. (Reuters)
The higher-growth brands are showing strong momentum: Bloomingdale’s comparable sales increased 11.3% in the second quarter, its highest second-quarter sales volume, while Bluemercury grew 6.2%. (SEC)
The operational reset is gaining traction, with companywide comparable sales positive for a fifth consecutive quarter and Reimagine 200 stores outperforming the broader Macy’s banner; the strategy is also supported by ongoing dividends and share repurchases. (SEC)
The core Macy’s banner remains sluggish: second-quarter comparable sales rose only 1.1%, versus 11.3% at Bloomingdale’s and 6.2% at Bluemercury, leaving the portfolio increasingly dependent on higher-income and luxury customers. (Reuters)
Second-quarter adjusted EPS benefited from a $0.23-per-share net tariff-refund contribution, making the reported 80% profit increase less representative of recurring earnings power. (Reuters)
The turnaround still requires substantial store rationalization and investment: Macy’s has extended its store-closure timetable through 2028, while closures continue to pressure reported sales and the company remains exposed to tariffs, energy costs and uneven discretionary spending. (AP)
Data summarised monthly by Lightyear AI. Last updated on 11 Sept 2026.
Macy's Financial Performance
Revenues and expenses
Macy's Earnings Performance
Company profitability
Upcoming events
Macy's News
AllArticlesVideos

Macy's rival might nab coveted ad space on corner of NYC flagship, setting up potential legal fight
New York Post1 day ago

Macy's Says Bold New Chapter Strategy Is Driving Sales Growth at Investor Conference
MarketBeat1 week ago

Macy's Falls on Guidance Despite Sales Beat, Better Outlook
Bloomberg Markets and Finance2 weeks ago
Funds containing Macy's
AllUSDGBPEUR
Fund name | Fund size | $M weighting |
|---|---|---|
SPDR S&P 400 US Mid Cap$SPY4 | $6.3B | 0.17% |
SPDR S&P 400 US Mid Cap£SPX4 | £4.7B | 0.17% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | €2.8B | 0.10% |
iShares MSCI USA Small Cap CTB Enhanced ESG£CUS1 | £2.4B | 0.10% |
iShares MSCI World Small Cap$WSML | $9B | 0.06% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.